Horizon Discovery (Horizon) has announced it has signed a commercial agreement with Belgian computational fragment based drug discovery biotech Silicos NV (Silicos) relating to its X-MAN technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results